Federfarma has published on its website a report on the trend in expenditure on price-controlled pharmaceuticals at the national and regional level for 2014. The document states that “NHS net price-controlled pharmaceutical expenditure in 2014 has decreased by 3.1% compared to 2013. The drop in spending for 2013 (for the seventh consecutive year) was reduced by 2.5%.”

The compete document is available at the following link.